SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-168479
Filing Date
2024-06-26
Accepted
2024-06-26 06:14:53
Documents
29
Period of Report
2024-06-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d834815d8k.htm   iXBRL 8-K 31537
2 EX-99.1 d834815dex991.htm EX-99.1 8936
3 EX-99.2 d834815dex992.htm EX-99.2 65709
7 GRAPHIC g834815g00o78.jpg GRAPHIC 66244
8 GRAPHIC g834815g03u81.jpg GRAPHIC 108411
9 GRAPHIC g834815g0625233003460.jpg GRAPHIC 4466
10 GRAPHIC g834815g07f17.jpg GRAPHIC 37651
11 GRAPHIC g834815g10w21.jpg GRAPHIC 38949
12 GRAPHIC g834815g12v58.jpg GRAPHIC 64330
13 GRAPHIC g834815g26m06.jpg GRAPHIC 38350
14 GRAPHIC g834815g29g39.jpg GRAPHIC 60800
15 GRAPHIC g834815g34o62.jpg GRAPHIC 114508
16 GRAPHIC g834815g51j09.jpg GRAPHIC 39151
17 GRAPHIC g834815g79j42.jpg GRAPHIC 69770
18 GRAPHIC g834815g88y18.jpg GRAPHIC 61785
19 GRAPHIC g834815g92s54.jpg GRAPHIC 91679
20 GRAPHIC g834815g98o95.jpg GRAPHIC 35357
  Complete submission text file 0001193125-24-168479.txt   1402676

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tsha-20240625.xsd EX-101.SCH 2844
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tsha-20240625_lab.xml EX-101.LAB 18737
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tsha-20240625_pre.xml EX-101.PRE 11703
32 EXTRACTED XBRL INSTANCE DOCUMENT d834815d8k_htm.xml XML 3767
Mailing Address 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS TX 75247
Business Address 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS TX 75247 (214) 612-0000
Taysha Gene Therapies, Inc. (Filer) CIK: 0001806310 (see all company filings)

IRS No.: 843199512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39536 | Film No.: 241070562
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)